Log In
Print this Print this

Aseptic loosing therapy

  Manage Alerts
Collapse Summary General Information
Company Broadvector Ltd.
DescriptionAn injection of an adenovirus serotype 5 (Ad5) vector encoding E. coli nitroreductase, followed by an injection of a prodrug which the enzyme converts into an undisclosed DNA cross-linking agent
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat aseptic loosening in hip implant failure patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today